Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:51 AM
Ignite Modification Date:
2025-12-25 @ 4:51 AM
NCT ID:
NCT03013218
Eligibility Criteria:
Inclusion Criteria:
* Histological or cytological diagnosis of advanced/metastatic solid tumor malignancy; or relapsed or refractory Non-Hodgkin lymphoma for whom no standard therapy is available..
* Adequate Bone Marrow Function.
* Adequate Renal \& Liver Function.
* Adequate Performance Status
Exclusion Criteria:
* Patients with known symptomatic CNS metastases or lepotomeningeal disease requiring steroids.
* Previous high-dose chemotherapy requiring allogenic stem cell rescue.
* Prior treatment with a CD47 or signal regulatory protein (SIRP) alpha targeting agent.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03013218
Study Brief:
Protocol Section:
NCT03013218